ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 708446 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 708446; 2) Community: the network communities that were significantly associated with the response to NSC 708446; 3) Molecule: the relationships between components within communities and NSC 708446; 4) MDR: the compounds that were significantly associated with the NSC 708446.

NSC Compound Enrichment Correlation
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.000307626816596602 0.6436714
NSC 747458 Null 0.000323852502732648 0.45422118
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.000380874609232497 0.59861837
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.000380874609232502 0.31470991
NSC 670656 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer 0.000395532514722381 0.71269957
NSC 683555 Camptothecin Derivative 0.000395532514722381 0.72376551
NSC 724003 5-Chloro-pyrazine-2-carboxylic acid benzylamide 0.000395532514722381 -0.11116998
NSC 671311 Null 0.00057400073542549 0.22149361
NSC 663790 Null 0.000613547200832843 0.70045775
NSC 743408 Null 0.000613547200832843 0.19521641
Total:63  Current:1    [First] [Prev] [Next] [Last]